etanercept


Also found in: Thesaurus, Medical, Wikipedia.
Related to etanercept: infliximab

e·tan·er·cept

 (ĭ-tăn′ər-sĕpt′)
n.
A drug that blocks tumor necrosis factor receptors and is used to treat autoimmune diseases, especially rheumatoid arthritis and psoriasis.

[eta-, origin unknown + -nercept, tumor necrosis factor receptor suffix (ne(c)r(osis) + (re)cept(or)).]
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.etanercept - a genetically engineered anti-TNF compound (trade name Enbrel) consisting of receptors that bind TNF; it is injected twice a week in the treatment of rheumatoid arthritis
anti-TNF compound - a class of drugs that block the action of tumor necrosis factor (TNF); used in cases of rheumatoid arthritis because TNF instigates inflammation of the joints
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations

etanercept

n etanercept m
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
Mentioned in ?
References in periodicals archive ?
Currently approved and recommended bDMARDs comprise the tumor necrosis factor inhibitors (TNFis) adalimumab, certolizumab pegol, etanercept, golimumab, and infliximab, and the monoclonal antibodies ustekinumab, which targets interleukin (IL)-12/23, and secukinumab and ixekizumab, which target IL-17A.
District Court for the District of New Jersey has ruled in Amgen's favor on validity of the two patents that describe and claim Enbrel[R] (etanercept) and methods for making it.
Enbrel - also known as etanercept - is owned by US pharmaceutical firm Amgen Inc.
MONDAY, July 15, 2019 (HealthDay News) -- Patients with autoimmune diseases have an increased risk for being diagnosed with Crohn disease (CD) or ulcerative colitis (UC) while under treatment with etanercept, according to a study published online July 2 in Alimentary Pharmacology and Therapeutics.
CHICAGO -- Etanercept monotherapy showed greater efficacy, compared with methotrexate monotherapy for the treatment of psoriatic arthritis (PsA), and combining the two agents provided no benefit over etanercept alone for most outcomes in the phase 3 SEAM-PsA (Etanercept and Methotrexate in Subjects With Psoriatic Arthritis) study.
These biologic agents in the treatment of psoriasis include monoclonal antibodies specific to TNF-[alpha] (infliximab, adalimumab), fusion proteins targeting TNF-[alpha] (etanercept), T cells (alefacept) and the p40 subunit of interleukin (IL)-12/IL-23 (ustekinumab) (6).
(2) Etanercept is a recombinant fusion protein that inhibits tumor necrosis factor-a (TNF-[alpha]), a cytokine that acts on several cell types to promote inflammation.
M2 PHARMA-June 28, 2018-Lupin partners with Mylan to commercialise Enbrel (Etanercept) Biosimilar
Global Banking News-June 28, 2018-Lupin partners with Mylan to commercialise Enbrel (Etanercept) Biosimilar
M2 EQUITYBITES-June 28, 2018-Lupin partners with Mylan to commercialise Enbrel (Etanercept) Biosimilar
Leading chemical company LG Chem said Wednesday that it has started selling etanercept biosimilar products in Japan after obtaining regulatory approval to market the products there.